Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of …
18 hours ago · According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success rate (PTSR) indication benchmark for progressing into Phase III. GlobalData’s report assesses how Tevimbra’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.
FDA Approves Zanidatamab for Biliary Tract Cancers With High …
On November 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to the drug zanidatamab (Ziihera ®) to treat advanced and metastatic bile duct cancer (cholangiocarcinoma) and other biliary tract cancers that have high levels of a protein called HER2 and do not respond to chemotherapy.
What’s New in Gallbladder Cancer Research?
Research into causes, prevention, and treatment of gallbladder cancer is ongoing in many medical centers throughout the world. Find out what's new here.
Gallbladder Cancer: Progress and Hope for Future Breakthroughs
Feb 8, 2024 · February is Gallbladder Cancer Awareness Month, and while it may be less common than other cancers, it's crucial to understand the latest advancements and future directions in diagnosis, treatment, and care.
Encouraging Treatment Advances for Aggressive Cancers of the …
Feb 6, 2023 · Two studies published in AACR journals identified increased weight and chronic exposure to arsenic in drinking water as modifiable factors that may elevate the risk of developing gallbladder cancer.
Gallbladder - latest research news and features - Medical Xpress
Each year, approximately 2,000 people die annually of gallbladder cancer (GBC) in the U.S., with only one in five cases diagnosed at an early stage. With GBC rated as the first biliary tract...
Durvalumab Modestly Improves Survival in Advanced Biliary Tract Cancer
Feb 10, 2022 · New results from a large clinical trial offer a glimmer of hope for people with biliary tract cancer, a rare but aggressive form of cancer, which can include bile duct cancer or gallbladder cancer. The study, called TOPAZ-1, found that adding the immunotherapy drug durvalumab (Imfinzi) to standard chemotherapy modestly extended how long people ...
Robotic-assisted surgery for gallbladder cancer as effective as ...
Mar 5, 2024 · The researchers believe these findings are significant since they suggest robotic surgery is a safer and potentially less painful option for gallbladder cancer treatment, with a faster recovery...
Gall bladder cancer - Latest research and news | Nature
Jun 17, 2024 · Gallbladder cancer is the most common cancer of the biliary tract and often has a very poor prognosis. This Primer by Roa and colleagues summarizes the epidemiology,...
Cancer Research News | Gallbladder Cancer - American Cancer …
Feb 26, 2019 · Gallbladder Cancer | Get the latest cancer research news about the work of our American Cancer Society staff researchers and research grantees.